Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification

Cellular Oncology

Volumn 34, Issue 3, 2011, Pages 261-275

  Klink, Barbara ^a   Schlingelhof, Ben ^a   Klink, Martin ^a,c   Stout Weider, Karen ^d   Patt, Stephan ^b   Schrock, Evelin ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c DEUTSCHER WETTERDIENST   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CGH; GBMO; Genetic subclassification; Genetics; Glioblastoma; Interphase FISH; Oligodendroglial component

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; GENETIC SUBCLASSIFICATION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; OLIGODENDROGLIAL DIFFERENTIATION; PRIORITY JOURNAL; CLASSIFICATION; GENETICS; HUMAN CHROMOSOME; INTERPHASE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLIGODENDROGLIA; PATHOLOGY; SURVIVAL;

ADULT; AGED; ASTROCYTES; CHROMOSOMES, HUMAN; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLIGODENDROGLIA; SURVIVAL ANALYSIS;

EID: 84555178467     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0034-8     Document Type: Article

References (59)

1. S.W. Coons, P.C. Johnson, B.W. Scheithauer, A.J. Yates, D.K. Pearl, Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79, 1381-1393 (1997) (Pubitemid 27143246)
2. C.E. Fuller, R.E. Schmidt, K.A. Roth, P.C. Burger, B.W. Scheithauer, R. Banerjee, K. Trinkaus, R. Lytle, A. Perry, Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features. J. Neuropathol. Exp. Neurol. 62, 1118-1128 (2003) (Pubitemid 37413823)
3. K. Ueki, R. Nishikawa, Y. Nakazato, T. Hirose, J. Hirato, N. Funada, T. Fujimaki, S. Hojo, O. Kubo, T. Ide, M. Usui, C. Ochiai, S. Ito, H. Takahashi, A. Mukasa, A. Asai, T. Kirino, Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin. Cancer Res. 8, 196-201 (2002) (Pubitemid 34101478)
4. H. Ohgaki, P. Kleihues, Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J. Neuropathol. Exp. Neurol. 64, 479-489 (2005) (Pubitemid 40781150)
5. C. Daumas-Duport, B. Scheithauer, J. O'Fallon, P. Kelly, Grading of astrocytomas. A simple and reproducible method. Cancer 62, 2152-2165 (1988) (Pubitemid 18261854)
6. C.R. Miller, A. Perry, Glioblastoma. Arch. Pathol. Lab. Med. 131, 397-406 (2007)
7. S.H. Bigner, E. Schrock, Molecular cytogenetics of brain tumors. J. Neuropathol. Exp. Neurol. 56, 1173-1181 (1997) (Pubitemid 27492773)
8. A.Misra,M. Pellarin, J.Nigro, I. Smirnov, D.Moore, K.R. Lamborn, D. Pinkel, D.G. Albertson, B.G. Feuerstein, Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma. Clin. Cancer Res. 11, 2907-2918 (2005) (Pubitemid 40525192)
9. S. Patt, H. Gries, M. Giraldo, J. Cervos-Navarro, H. Martin, W. Jänisch, J. Brockmöller, p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas. Hum. Pathol. 27, 586-589 (1996) (Pubitemid 26187283)
10. B. Tews, J. Felsberg, C. Hartmann, A. Kunitz, M. Hahn, G. Toedt, K. Neben, L. Hummerich, A. von Deimling, G. Reifenberger, P. Lichter, Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling. Int. J. Cancer 119, 792-800 (2006) (Pubitemid 44051441)
11. G. Cairncross, B. Berkey, E. Shaw, R. Jenkins, B. Scheithauer, D. Brachman, J. Buckner, K. Fink, L. Souhami, N. Laperierre, M. Mehta, W. Curran, Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J. Clin. Oncol. 24, 2707-2714 (2006) (Pubitemid 46630566)
12. J.G. Cairncross, K. Ueki, M.C. Zlatescu, D.K. Lisle, D.M. Finkelstein, R.R. Hammond, J.S. Silver, P.C. Stark, D.R. Macdonald, Y. Ino, D.A. Ramsay, D.N. Louis, Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl Cancer Inst. 90, 1473-1479 (1998) (Pubitemid 28482012)
13. J.S. Smith, A. Perry, T.J. Borell, H.K. Lee, J. O'Fallon, S.M. Hosek, D. Kimmel, A. Yates, P.C. Burger, B.W. Scheithauer, R.B. Jenkins, Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J. Clin. Oncol. 18, 636-645 (2000) (Pubitemid 30078545)
14. M.J. van den Bent, A.F. Carpentier, A.A. Brandes, M. Sanson, M. J.B. Taphoorn, H.J.J.A. Bernsen, M. Frenay, C.C. Tijssen, W. Grisold, L. Sipos, H. Haaxma-Reiche, J.M. Kros, M.C.M. van Kouwenhoven, C.J. Vecht, A. Allgeier, D. Lacombe, T. Gorlia, Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J. Clin. Oncol. 24, 2715-2722 (2006) (Pubitemid 46630567)
15. J. Felsberg, A. Erkwoh, M.C. Sabel, L. Kirsch, R. Fimmers, B. Blaschke, U. Schlegel, J. Schramm, O.D. Wiestler, G. Reifenberger, Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival. Brain Pathol. 14, 121-130 (2004) (Pubitemid 38656383)
16. G. Reifenberger, D.N. Louis, Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J. Neuropathol. Exp. Neurol. 62, 111-126 (2003) (Pubitemid 36176946)
17. S.H. Bigner, M.R. Matthews, B.K. Rasheed, R.N. Wiltshire, H.S. Friedman, A.H. Friedman, T.T. Stenzel, D.M. Dawes, R.E. McLendon, D.D. Bigner, Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am. J. Pathol. 155, 375-386 (1999) (Pubitemid 29370388)
18. C. Decaestecker, I. Camby, L. Gordower, O. Dewitte, P. Cras, J.J. Martin, J.L. Pasteels, P.V. Ham, J. Brotchi, R. Kiss, I. Salmon, Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy. J. Neuropathol. Exp. Neurol. 57, 791-802 (1998) (Pubitemid 28378156)
19. J. He, K. Mokhtari, M. Sanson, Y. Marie, M. Kujas, S. Huguet, P. Leuraud, L. Capelle, J.Y. Delattre, J. Poirier, K. Hoang-Xuan, Glioblastomas with an oligodendroglial component: a pathological and molecular study. J. Neuropathol. Exp. Neurol. 60, 863-871 (2001) (Pubitemid 32880594)
20. J.A. Kraus, K. Lamszus, N. Glesmann, M. Beck, M. Wolter, M. Sabel, D. Krex, T. Klockgether, G. Reifenberger, U. Schlegel, Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol (Berl) 101, 311-320 (2001) (Pubitemid 32372420)
21. J.W. Jeuken, S.H. Sprenger, R.H. Boerman, A. von Deimling, H. L. Teepen, J.J. van Overbeeke, P. Wesseling, Subtyping of oligoastrocytic tumours by comparative genomic hybridization. J. Pathol. 194, 81-87 (2001)
22. C. Walker, D.G. du Plessis, K.A. Joyce, Y. Machell, J. Thomson-Hehir, S.A.A. Haddad, J.C. Broome, P.C. Warnke, Phenotype versus genotype in gliomas displaying inter-or intratumoral histological heterogeneity. Clin. Cancer Res. 9, 4841-4851 (2003) (Pubitemid 37323288)
23. D.A. Hilton, M. Penney, L. Pobereskin, H. Sanders, S. Love, Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival. Histopathology 44, 555-560 (2004) (Pubitemid 38845101)
24. P. Kleihues, P.C. Burger, K.D. Aldape, D.J. Brat, W. Biernat, D.D. Bigner, Y. Nakazato, K.H. Plate, F. Giangaspero, A. von Deimling, H. Ohgaki, W.K. Cavenee, Glioblastoma, in WHO Classification of Tumours of the Central Nervous System, ed. by D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee (International Agency for Research on Cancer (IARC) Press, Lyon, 2007), pp. 33-49
25. P. Kleihues, W.K. Cavenee, Pathology and Genetics of Tumours of the Nervous System, World Health Organization Classification of Tumours (International Agency for Research on Cancer (IARC) Press, Lyon, 2000)
26. R. Koschny, T. Koschny, U.G. Froster, W. Krupp, M.A. Zuber, Comparative genomic hybridization in glioma: a meta-analysis of 509 cases. Cancer Genet. Cytogenet. 135, 147-159 (2002) (Pubitemid 34786766)
27. E. Schrock, C. Blume, M.C. Meffert, S. du Manoir, W. Bersch, M. Kiessling, T. Lozanowa, G. Thiel, R. Witkowski, T. Ried, T. Cremer, Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomic hybridization. Genes Chromosom. Cancer 15, 199-205 (1996) (Pubitemid 26115928)
28. C. Lengauer, I. Dunham, T. Featherstone, T. Cremer, Generation of alphoid DNA probes for fluorescence in situ hybridization (FISH) using the polymerase chain reaction. Methods Mol. Biol. 33, 51-61 (1994)
29. E. Schrock, G. Thiel, T. Lozanova, S. du Manoir, M.C. Meffert, A. Jauch, M.R. Speicher, P. Nürnberg, S. Vogel, W. Jänisch, Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am. J. Pathol. 144, 1203-1218 (1994) (Pubitemid 24172083)
30. N. Aldosari, R.N. Wiltshire, A. Dutra, E. Schrock, R.E. McLendon, H.S. Friedman, D.D. Bigner, S.H. Bigner, Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft. Neuro. Oncol. 4, 75-85 (2002) (Pubitemid 34285061)
31. P.H. Wessels, A. Twijnstra, A.G.H. Kessels, B. Krijne-Kubat, P.H. Theunissen, M.I.J. Ummelen, F.C.S. Ramaekers, A.H. Hopman, Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2. Genes Chromosom. Cancer 33, 279-284 (2002) (Pubitemid 34130934)
32. K.S. Reddy, Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas. Cancer Genet. Cytogenet. 184, 77-86 (2008) (Pubitemid 351915763)
33. T. Nagasaka, M. Gunji, N. Hosokai, K. Hayashi, H. Ikeda, M. Ito, S. Inao, FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma. Brain Tumor Pathol. 24, 1-5 (2007) (Pubitemid 46836348)
34. C.A. Klein, O. Schmidt-Kittler, J.A. Schardt, K. Pantel, M.R. Speicher, G. Riethmüller, Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl Acad. Sci. U.S.A. 96, 4494-4499 (1999) (Pubitemid 29190364)
35. W. Paulus, J. Peiffer, Intratumoral histologic heterogeneity of gliomas. A quantitative study. Cancer 64, 442-447 (1989) (Pubitemid 19180407)
36. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, P. Kleihues, The 2007WHO classification of tumours of the central nervous system. Acta Neuropathol. 114, 97-109 (2007) (Pubitemid 47103521)
37. Y. Nakazato, K.H. Plate, F. Giangaspero, A. von Deimling, H. Ohgaki, W.K. Cavenee, Glioblastoma, in WHO Classification of Tumours of the Nervous System, ed. by D.N. Louis, H. Ohgaki, O. D. Wiestler, W.K. Cavenee (IARC, Lyon, 2007), pp. 33-49
38. J.E. Bromberg, M.J. van den Bent, Oligodendrogliomas: Molecular biology and treatment. Oncologist 14, 155-163 (2009)
39. T. Nishizaki, S. Ozaki, K. Harada, H. Ito, H. Arai, T. Beppu, K. Sasaki, Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosom. Cancer 21, 340-346 (1998) (Pubitemid 28165042)
40. A. von Deimling, D.N. Louis, K. von Ammon, I. Petersen, T. Hoell, R.Y. Chung, R.L. Martuza, D.A. Schoenfeld, M.G. Yasargil, O.D. Wiestler, Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J. Neurosurg. 77, 295-301 (1992)
41. C.A. Griffin, P. Burger, L.Morsberger, R. Yonescu, S. Swierczynski, J.D.Weingart, K.M. Murphy, Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. J. Neuropathol. Exp. Neurol. 65, 988-994 (2006) (Pubitemid 44521799)
42. R.B. Jenkins, H. Blair, K.V. Ballman, C. Giannini, R.M. Arusell, M. Law, H. Flynn, S. Passe, S. Felten, P.D. Brown, E.G. Shaw, J. C. Buckner, A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res. 66, 9852-9861 (2006) (Pubitemid 44672036)
43. K. Ichimura, A.P. Vogazianou, L. Liu, D.M. Pearson, L.M. Backlund, K. Plant, K. Baird, C.F. Langford, S.G. Gregory, V.P. Collins, 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas. Oncogene 27, 2097-2108 (2008) (Pubitemid 351442746)
44. A. Idbaih, Y. Marie, G. Pierron, C. Brennetot, K. Hoang-Xuan, M. Kujas, K.Mokhtari,M. Sanson, J. Lejeune, A. Aurias, O. Delattre, J. Y. Delattre, Two types of chromosome 1p losses with opposite significance in gliomas. Ann. Neurol. 58, 483-487 (2005) (Pubitemid 41266639)
45. A. Korshunov, R. Sycheva, A. Golanov, The prognostic relevance of molecular alterations in glioblastomas for patients age <50 years. Cancer 104, 825-832 (2005) (Pubitemid 41113684)
46. H. Ohgaki, P. Kleihues, Genetic pathways to primary and secondary glioblastoma. Am. J. Pathol. 170, 1445-1453 (2007) (Pubitemid 47339290)
47. M.C. Schmidt, S. Antweiler, N. Urban, W. Mueller, A. Kuklik, B. Meyer-Puttlitz, O.D. Wiestler, D.N. Louis, R. Fimmers, A. von Deimling, Impact of genotype and morphology on the prognosis of glioblastoma. J. Neuropathol. Exp. Neurol. 61, 321-328 (2002) (Pubitemid 34266783)
48. T.C.G.A.R. Network, Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008)
49. T. Homma, T. Fukushima, S. Vaccarella, Y. Yonekawa, P.L.D. Patre, S. Franceschi, H. Ohgaki, Correlation among pathology, genotype, and patient outcomes in glioblastoma. J. Neuropathol. Exp. Neurol. 65, 846-854 (2006) (Pubitemid 44371230)
50. M. Salvati, A.I. Formichella, A. D'Elia, C. Brogna, A. Frati, F. Giangaspero, R. Delfini, A. Santoro, Cerebral glioblastoma with oligodendrogliomal component: analysis of 36 cases. J. Neurooncol. 94, 129-134 (2009)
51. L.W. Pinto, M.B. Araujo, A.L. Vettore, L. Wernersbach, A.C. Leite, L.M. Chimelli, F.A. Soares, Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis. Virchows Arch. 452, 481-490 (2008)
52. J.A. Kraus, J. Koopmann, P. Kaskel, D. Maintz, S. Brandner, J. Schramm, D.N. Louis, O.D. Wiestler, A. von Deimling, Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J. Neuropathol. Exp. Neurol. 54, 91-95 (1995)
53. M. Qu, T. Olofsson, S. Sigurdardottir, C. You, H. Kalimo, M. Nister, A. Smits, Z.P. Ren, Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas. Acta Neuropathol. 113, 129-136 (2007) (Pubitemid 46158146)
54. Z.-Q. Dong, J.C.-S. Pang, C.Y.-K. Tong, L.-F. Zhou, H.-K. Ng, Clonality of oligoastrocytomas. Hum. Pathol. 33, 528-535 (2002) (Pubitemid 34747873)
55. D. Trost, M. Ehrler, R. Fimmers, J. Felsberg, M.C. Sabel, L. Kirsch, J. Schramm, O.D. Wiestler, G. Reifenberger, R.G. Weber, Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors. Int. J. Cancer 120, 2368-2376 (2007) (Pubitemid 46642123)
56. K.B. Fallon, C.A. Palmer, K.A. Roth, L.B. Nabors, W. Wang, M. Carpenter, R. Banerjee, P. Forsyth, K. Rich, A. Perry, Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. J. Neuropathol. Exp. Neurol. 63, 314-322 (2004) (Pubitemid 38429028)
57. M. Nakamura, F. Yang, H. Fujisawa, Y. Yonekawa, P. Kleihues, H. Ohgaki, Loss of heterozygosity on chromosome 19 in secondary glioblastomas. J. Neuropathol. Exp. Neurol. 59, 539-543 (2000) (Pubitemid 30368313)
58. R.G.Weber,M. Sabel, J. Reifenberger, C. Sommer, J. Oberstrass, G. Reifenberger, M. Kiessling, T. Cremer, Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13, 983-994 (1996) (Pubitemid 26329085)
59. E.C. Wooten, D. Fults, R. Duggirala, K. Williams, A.P. Kyritsis, M.L. Bondy, V.A. Levin, P. O'Connell, A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution. Neuro. Oncol. 1, 169-176 (1999)